A study published in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD), estimates the prevalence of people living with type…
MedEngine Oy announced today that it has acquired the Institute of Applied Economics and Health Research ApS (ApHER), a leading Danish medical data science company.…
Finnish Haemophilia patients have comprehensive followup and most receive factor replacement therapy, shows the results from the HemoHEOR study which was published this week in…
Obesity has a significant negative impact on quality of life (QoL) and perceived physical and psychological working ability. This summarizes the first results of the…
MedEngine has been granted a partnership in the European Network of Centres for Pharmacoepidemiology & Pharmacovigilance (ENCePP), an initiative that brings together expertise and resources…
THL Biobank, a nationwide biobank hosted by the Finnish Institute for Health and Welfare, and MedEngine Oy, a company specialized in high-quality medical data science…
Haemophilia treatment in Finnish university hospitals is of excellent quality and at costs reasonable within European standards, shows the HemoHEOR study conducted by MedEngine that…
A real-world registry study, recently accepted for publication in the Journal of Alzheimer’s Disease, demonstrates an association between the early initiation of anti-dementia medication and…
A recently published real-world cohort study demonstrated that vedolizumab, an anti-integrin antibody, is an effective and well-tolerated treatment option for patients with inflammatory bowel disease (IBD). The…
The 20th Annual European Congress of The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) was held in Glasgow, Scotland on Nov 4–8th 2017. The event attracted…